Vaishali Pharma Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 262.38 million compared to INR 254.08 million a year ago. Revenue was INR 267.67 million compared to INR 259.59 million a year ago. Net income was INR 4.36 million compared to INR 2.03 million a year ago. Basic earnings per share from continuing operations was INR 0.41 compared to INR 0.19 a year ago. Diluted earnings per share from continuing operations was INR 0.06 compared to INR 0.19 a year ago.
For the full year, sales was INR 696.63 million compared to INR 758.21 million a year ago. Revenue was INR 718.92 million compared to INR 776.09 million a year ago. Net income was INR 66.03 million compared to INR 40.24 million a year ago. Basic earnings per share from continuing operations was INR 6.26 compared to INR 3.82 a year ago. Diluted earnings per share from continuing operations was INR 5.91 compared to INR 3.82 a year ago.